TOMDF (Todos Medical) Total Stockholders Equity: $-31.21 Mil (As of Sep. 2022)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Todos Medical Total Stockholders Equity?

Todos Medical TOMDF -90.00% Total Stockholders Equity is $-31.21 Mil as of Sep. 2022.

Todos Medical's Total Stockholders Equity for the quarter that ended in Sep. 2022 was $-31.21 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Todos Medical's Book Value per Share for the quarter that ended in Sep. 2022 was $-0.02. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Todos Medical's Debt-to-Equity for the quarter that ended in Sep. 2022 was -1.15.

Todos Medical  (OTCPK:TOMDF) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Todos Medical's Book Value per Share for the quarter that ended in Sep. 2022 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(-31.21-0)/1354.369
=-0.02

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Todos Medical's Debt-to-Equity for the quarter that ended in Sep. 2022 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(5.857 + 30.015) / -31.21
=-1.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Todos Medical Total Stockholders Equity Related Terms

Todos Medical Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Todos Medical's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Todos Medical Total Stockholders Equity Chart

Todos Medical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Total Stockholders Equity
Get a 7-Day Free Trial -1.34 -1.22 -6.25 -11.01 -24.21

Todos Medical Quarterly Data
Dec15 Dec16 Dec17 Dec18 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -10.50 -24.21 0.00 -30.40 -31.21
What does a Total Stockholders Equity of $-31.21 Mil mean?
Todos Medical (TOMDF) has a Total Stockholders Equity of $-31.21 Mil as of Sep. 2022. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Todos Medical and its competitors.
Is Todos Medical's Total Stockholders Equity too high?
Todos Medical's current Total Stockholders Equity is $-31.21 Mil.
How does Todos Medical's Total Stockholders Equity compare to NDRA and IDXG?
Todos Medical's Total Stockholders Equity of $-31.21 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Medical Diagnostics & Research company?
A good Total Stockholders Equity depends on the Medical Diagnostics & Research industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Todos Medical and its competitors. Todos Medical's current Total Stockholders Equity is $-31.21 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Todos Medical stock overvalued right now?
Todos Medical (TOMDF) has a current Total Stockholders Equity of $-31.21 Mil. The current Total Stockholders Equity is $-31.21 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Todos Medical (TOMDF), the current Total Stockholders Equity is $-31.21 Mil as of Sep. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Todos Medical Business Description

Address 121 Derech Menachem Begin, 30th Floor, Tel Aviv, ISR, 6701203
Todos Medical Ltd is an in vitro diagnostics company. Its operating segments are Breast Cancer Test, Alzheimer's, and COVID-19 testing. The company generates all of its revenue from the United States.